Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Study to Evaluate the Effect of Flow-Regulated Ventriculoperitoneal Shunting on Progression of Alzheimer's Disease: An Investigation of the Safety and Effectiveness of the COGNIShunt® CNS Shunt System
Authors not listed
Eunoe · 2001
Abstract
This is a study of the effect on the progression of Alzheimer's Disease of a surgically implanted shunt (tube) to increase the flow of cerebrospinal fluid and improve the clearance of potential neurotoxins from the fluid bathing the brain.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-02 MST
Cite this
APA
Anonymous. (2001). Study to Evaluate the Effect of Flow-Regulated Ventriculoperitoneal Shunting on Progression of Alzheimer's Disease: An Investigation of the Safety and Effectiveness of the COGNIShunt® CNS Shunt System. <em>Eunoe</em>. https://clinicaltrials.gov/study/NCT00056628
Vancouver
Anonymous. Study to Evaluate the Effect of Flow-Regulated Ventriculoperitoneal Shunting on Progression of Alzheimer's Disease: An Investigation of the Safety and Effectiveness of the COGNIShunt® CNS Shunt System. Eunoe. 2001.
BibTeX
@misc{anon2001Studyt,
title = {Study to Evaluate the Effect of Flow-Regulated Ventriculoperitoneal Shunting on Progression of Alzheimer's Disease: An Investigation of the Safety and Effectiveness of the COGNIShunt® CNS Shunt System},
author = {Anonymous},
journal = {Eunoe},
year = {2001},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neuroscience Letters 2013
Preprint · OA
Klotho in the cerebrospinal fluid of adults with and without Alzheimer's disease
Brain Research 1999
Citation only
Increased cerebrospinal fluid cAMP levels in Alzheimer's disease
Eli Lilly and Company 2016
Open access · US-GOV
Effect of LY3202626 on Alzheimer's Disease Progression as Measured by Cerebral ¹⁸F-AV-1451 Tau-PET in Mild Alzheimer's Disease Dementia
US Department of Veterans Affairs 1998
Open access · US-GOV
Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen
Lewis Lipsitz 2022
Open access · US-GOV
Senolytics To Alleviate Mobility Issues and Neurological Impairment in Aging
Eli Lilly and Company 2026
Open access · US-GOV